WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,400.00
-500.00 (-6.33%)
At close: Sep 11, 2026

KOSDAQ:330350 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
18,87217,39017,8939,1739,01213,831
Short-Term Investments
1,0001,0001,0001,00010,5002,500
Trading Asset Securities
1,0021,051-1,0197,04426,147
Cash & Short-Term Investments
20,87419,44018,89311,19226,55642,478
Cash Growth
-9.46%2.90%68.81%-57.85%-37.48%7.72%
Accounts Receivable
26,32925,55622,10525,79717,83518,635
Other Receivables
37.8128.2444.94292.4377.4278.45
Receivables
29,54129,20626,09930,97823,37224,228
Inventory
19,48119,07016,15116,0049,0218,141
Prepaid Expenses
74.7721.1824.0143.49317.71,523
Other Current Assets
2.442.285.2129.52183.7958.6
Total Current Assets
69,97467,74061,17358,24759,45176,427
Property, Plant & Equipment
50,52947,53149,23649,94539,84325,379
Long-Term Investments
11,2469,44311,88112,0999,6378,733
Other Intangible Assets
4,5244,5404,5732,5322,5281,548
Long-Term Accounts Receivable
00-0-00-0
Long-Term Deferred Tax Assets
2,4572,1501,4711,1981,5491,380
Long-Term Deferred Charges
5,1875,1206,2666,3155,8935,035
Other Long-Term Assets
111.92120.5687.95443.21493.87476.13
Total Assets
144,029136,645134,687130,780119,395118,979

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,9214,9283,6207,1903,4472,435
Accrued Expenses
1,2051,1991,1911,0661,0371,154
Short-Term Debt
17,00016,00019,00011,42412,51912,839
Current Portion of Long-Term Debt
1,1672,3332,3333,3332,0001,000
Current Portion of Leases
166.28166.06172.04201.49172.31280.27
Current Income Taxes Payable
-47.52298.63243.82645.94761.3
Other Current Liabilities
8,7658,1857,3237,5525,7525,506
Total Current Liabilities
34,22432,85933,93831,01125,57223,975
Long-Term Debt
--2,3334,6676,6008,700
Long-Term Leases
229.78224.95226.39375.14175.65285.61
Pension & Post-Retirement Benefits
5,6395,5545,0734,4494,0115,113
Other Long-Term Liabilities
-00000-
Total Liabilities
40,09338,63841,57140,50236,35938,074

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,6402,6402,6402,6402,6392,638
Additional Paid-In Capital
15,10915,10915,10915,10914,99714,948
Retained Earnings
85,51679,62374,73371,89464,73662,642
Treasury Stock
--35.66-35.66-35.66-35.66-35.66
Comprehensive Income & Other
670.63670.63670.63670.63700.16713.26
Shareholders' Equity
103,93698,00793,11790,27883,03680,905
Total Liabilities & Equity
144,029136,645134,687130,780119,395118,979

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
18,56318,72424,06520,00121,46723,105
Net Cash (Debt)
2,311716.07-5,172-8,8095,08919,373
Net Cash Growth
850.80%----73.73%-12.80%
Net Cash Per Share
175.0854.25-391.26-667.36385.931467.59
Filing Date Shares Outstanding
13.2113.213.213.213.1913.19
Total Common Shares Outstanding
13.2113.213.213.213.1913.19
Working Capital
35,74934,88127,23527,23633,87852,452
Book Value Per Share
7868.057424.927054.466839.416295.236135.62
Tangible Book Value
99,41293,46788,54487,74680,50879,357
Tangible Book Value Per Share
7525.587080.986708.036647.626103.586018.20
Land
10,6766,9856,9856,9856,5966,238
Buildings
34,89634,89634,89634,89610,0579,657
Machinery
22,71522,66221,82118,05014,25013,519
Construction In Progress
426.3622.479.41,97619,7515,838